-- 据《金融时报》周二报道，中国国有的“大基金”正在洽谈领投DeepSeek的下一轮融资，该轮融资的估值将达到450亿美元。 报道称，中国集成电路产业投资基金（该基金已投资中芯国际和其他半导体芯片厂商）有意主导此次融资，但最终细节尚未确定。 （市场动态新闻来源于与全球市场专业人士的对话。这些信息被认为来自可靠来源，但可能包含传闻和推测。准确性无法保证。）
Related Articles
Asia
Rundu Pharmaceutical Gets Nod to Market Losartan Potassium
Zhuhai Rundu Pharmaceutical (SHE:002923) obtained approval from China's National Medical Products Administration for the marketing of losartan potassium, according to a Shenzhen bourse filing on Wednesday.The drug is used for the treatment of primary hypertension and chronic heart failure.The pharmaceutical company's shares rose by less than 2% at the close.
$SHE:002923
International
Final PMI: UK Private Sector Growth Accelerates in April
Britain's private sector output growth increased in April, indicating a moderate rise in manufacturing production and in services sector activity, data from S&P Global showed.The seasonally adjusted S&P Global UK PMI Composite Output Index rose to 52.6 from 50.3 in March, according to final data published Wednesday. The flash estimate stood at 52.Meanwhile, the services PMI came in at 52.7, compared with the previous month's 50.5 and the preliminary reading of 52.
$^FTSE
Australia
Versigent Q1 Net Income Falls, Sales Rise
Versigent (VGNT) reported Q1 net income Tuesday of $81 million, down from $96 million a year earlier.Net sales for the quarter ended March 31 were $2.21 billion, up from $2.02 billion a year earlier.Analysts surveyed by FactSet expected $2.09 billion.The company said it expects 2026 revenue of $9.10 billion to $9.40 billion. Analysts surveyed by FactSet expect $9.25 billion.Shares of the company traded more than 5% higher in recent premarket activity Wednesday.Price: $39.39, Change: $+1.89, Percent Change: +5.04%
$VGNT